ATE527272T1 - Synthese von triphenylphosphoniumchinolen und - chinonen - Google Patents

Synthese von triphenylphosphoniumchinolen und - chinonen

Info

Publication number
ATE527272T1
ATE527272T1 AT02760924T AT02760924T ATE527272T1 AT E527272 T1 ATE527272 T1 AT E527272T1 AT 02760924 T AT02760924 T AT 02760924T AT 02760924 T AT02760924 T AT 02760924T AT E527272 T1 ATE527272 T1 AT E527272T1
Authority
AT
Austria
Prior art keywords
quinones
sub
triphenylphosphoniumquinoles
synthesis
typified
Prior art date
Application number
AT02760924T
Other languages
English (en)
Inventor
Robin Smith
Michael Murphy
Original Assignee
Antipodean Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antipodean Pharmaceuticals Inc filed Critical Antipodean Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE527272T1 publication Critical patent/ATE527272T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fireproofing Substances (AREA)
AT02760924T 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen ATE527272T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ513547A NZ513547A (en) 2001-08-13 2001-08-13 Synthesis of triphenylphosphonium quinols (e.g. mitoquinol) and/or quinones (e.g. mitoquinone)
PCT/NZ2002/000154 WO2003016323A1 (en) 2001-08-13 2002-08-12 Synthesis of triphenylphosphonium quinols snd quinones

Publications (1)

Publication Number Publication Date
ATE527272T1 true ATE527272T1 (de) 2011-10-15

Family

ID=19928579

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02760924T ATE527272T1 (de) 2001-08-13 2002-08-12 Synthese von triphenylphosphoniumchinolen und - chinonen

Country Status (5)

Country Link
US (1) US7179928B2 (de)
EP (1) EP1423396B1 (de)
AT (1) ATE527272T1 (de)
NZ (1) NZ513547A (de)
WO (1) WO2003016323A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060229278A1 (en) * 1998-11-25 2006-10-12 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US20080275005A1 (en) * 1998-11-25 2008-11-06 Murphy Michael P Mitochondrially targeted antioxidants
EP1664069B8 (de) * 2003-08-22 2015-07-01 Antipodean Pharmaceuticals, Inc. Als auf die mitochondrien zielende antioxidationsmittel verwendete mitochinonderivate
JP4648319B2 (ja) * 2003-08-22 2011-03-09 アンティポディーン ファーマシューティカルズ インコーポレイティド ミトコンドリアを標的とする抗酸化剤として使用されるミトキノン誘導体
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
CN1997403A (zh) * 2004-07-13 2007-07-11 奥里迪斯生物医学研究及开发有限责任公司 靶向线粒体的抗氧化剂在治疗肝病和上皮癌中的用途
ES2619303T3 (es) 2005-06-01 2017-06-26 Edison Pharmaceuticals, Inc. Productos terapéuticos redox activos para el tratamiento de enfermedades mitocondriales y otras afecciones y modulación de biomarcadores energéticos
SI1933821T1 (sl) * 2005-09-15 2020-11-30 Ptc Therapeutics, Inc. Repne variante redoks-aktivnih terapevtikov za zdravljenje mitohondrijskih bolezni in drugih bolezni ter modulacijo energijskih biooznačevalcev
WO2007100652A2 (en) 2006-02-22 2007-09-07 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EP2332534B1 (de) 2006-02-22 2018-11-14 Bioelectron Technology Corporation Phenol- und Benzoquinonederivate zur Verwendung in der Behandlung von Mitochondriopathien und zur Modulation von Energie-Biomarkern
WO2008086025A2 (en) * 2007-01-10 2008-07-17 Edison Pharmaceuticals, Inc. Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
EA038941B1 (ru) 2007-11-06 2021-11-12 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
US8952071B2 (en) * 2008-01-08 2015-02-10 Edison Pharmaceuticals, Inc. (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases
WO2009111576A2 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
US20090291092A1 (en) * 2008-05-22 2009-11-26 Miller Guy M Treatment of mitochondrial diseases with an erythropoietin mimetic
JP5798481B2 (ja) * 2008-06-25 2015-10-21 エジソン ファーマシューティカルズ, インコーポレイテッド 酸化ストレス疾患を治療するための2−ヘテロシクリルアミノアルキル−(p−キノン)誘導体
MX363223B (es) 2008-09-10 2019-03-15 Bioelectron Tech Corp Tratamiento de trastornos generalizados del desarrollo con terapeuticos con actividad redox.
JP6106157B2 (ja) 2011-04-26 2017-03-29 レトロトップ、 インコーポレイテッドRetrotope, Inc. 神経変性障害および筋疾患に関与するpufa
WO2012148930A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Oxidative retinal diseases
KR102112087B1 (ko) 2011-04-26 2020-05-18 레트로토프 인코포레이티드 에너지 프로세싱 손상 장애 및 미토콘드리아 결함
JP6145087B2 (ja) 2011-04-26 2017-06-07 レトロトップ、 インコーポレイテッドRetrotope, Inc. Pufa酸化関与障害
KR102137450B1 (ko) 2012-07-12 2020-07-27 콘드리온 아이피 비.브이. 미토콘드리아 질환을 치료하기 위한 크로마닐 유도체
CA2883882A1 (en) 2012-09-07 2014-03-13 Ptc Therapeutics, Inc. Benzoquinone derivatives for treating oxidative stress disorders
US9868711B2 (en) 2013-03-15 2018-01-16 Bioelectron Technology Corporation Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US9670170B2 (en) 2013-03-15 2017-06-06 Bioelectron Technology Corporation Resorufin derivatives for treatment of oxidative stress disorders
US10189830B2 (en) 2013-03-15 2019-01-29 Bioelectron Technology Corporation Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
US9296712B2 (en) 2013-03-15 2016-03-29 Edison Pharmaceuticals, Inc. Resorufin derivatives for treatment of oxidative stress disorders
EP3004071A1 (de) 2013-05-31 2016-04-13 Edison Pharmaceuticals, Inc. Carboxylderivate zur behandlung von erkrankungen in verbindung mit oxidativem stress
AU2015229240B9 (en) 2014-03-13 2019-05-02 Biojiva Llc Optic neuropathy treatment and reduction of steroid-induced oxidative stress with stabilized polyunsaturated substances
US9314457B2 (en) 2014-06-19 2016-04-19 The University Of Utah Research Foundation Methods of treating and preventing vascular instability diseases
DK3233786T3 (da) 2014-12-16 2022-05-09 Ptc Therapeutics Inc Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
US10815211B2 (en) 2015-10-08 2020-10-27 Khondrion Ip B.V. Compounds for treating mitochondrial disease
US10703701B2 (en) 2015-12-17 2020-07-07 Ptc Therapeutics, Inc. Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
CN110167546A (zh) 2016-11-17 2019-08-23 乐巢拓普有限公司 同位素修饰的组分及其治疗用途
WO2018129411A1 (en) 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
CN109793720B (zh) * 2019-01-28 2022-01-14 温州医科大学 一种基于透明质酸的线粒体靶向抗氧化剂Mito Q纳米制剂的制备方法及应用
US20230002324A1 (en) 2019-06-13 2023-01-05 Ptc Therapeutics, Inc. Naphthoquinone derivatives for treatment of oxidative stress disorders
CN114901290B (zh) * 2019-12-16 2024-09-03 蔚山科学技术院 抑制血管新生因子的化合物及其用途
WO2022019362A1 (ko) * 2020-07-24 2022-01-27 울산과학기술원 Tpp 유도체 화합물 및 이를 포함하는 노화 또는 노화 관련 질환의 치료 또는 예방을 위한 약학적 조성물
CN116390723B (zh) 2020-09-09 2024-12-31 社会利益网络公司 用于将生物素递送至线粒体的方法和组合物
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
WO2026008715A1 (en) 2024-07-02 2026-01-08 Université Catholique de Louvain Mitochondrially-targeted antioxidant compound for use in radiation therapy
CN118994239B (zh) * 2024-08-09 2025-09-26 苏州满元生物科技有限公司 氧化制备米托醌的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0237338B2 (ja) 1982-08-27 1990-08-23 Takeda Chemical Industries Ltd 99*3*44jimetokishii22hidorokishii66mechirubenzoiru*nonanoeetonoseizoho
EP0289223B1 (de) 1987-04-27 1992-09-02 Takeda Chemical Industries, Ltd. Reduktion von Carbonsäureestern
JPH07223991A (ja) 1993-12-17 1995-08-22 Takeda Chem Ind Ltd アシル置換芳香族化合物の製造法
JP2637705B2 (ja) 1995-03-02 1997-08-06 株式会社ナード研究所 ベンゾキノン系誘導体の製造法
US6331532B1 (en) * 1998-11-25 2001-12-18 University Of Otago Mitochondrially targeted antioxidants

Also Published As

Publication number Publication date
EP1423396B1 (de) 2011-10-05
NZ513547A (en) 2002-09-27
US7179928B2 (en) 2007-02-20
WO2003016323A1 (en) 2003-02-27
EP1423396A4 (de) 2006-02-22
US20050043553A1 (en) 2005-02-24
EP1423396A1 (de) 2004-06-02

Similar Documents

Publication Publication Date Title
ATE527272T1 (de) Synthese von triphenylphosphoniumchinolen und - chinonen
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
ATE270817T1 (de) Fungizide
HN2000000109A (es) Trifluorbutenos nematicidas
TR200001876T2 (tr) HIV proteaz inhibitörünün bisülfat tuzu.
RU96119782A (ru) Производные 7-амино-1h-индола
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
CY1113657T1 (el) Νεα παραγωγα βενζοφαινονης ή αλατα αυτων
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
BR0209984A (pt) Processo para a preparação de prostaglandinas e seus análogos
DE60229736D1 (de) Spiroinden- und spiroindan-verbindungen
ATE288900T1 (de) Substituierte benzoylcyclohexandione
SE0004245D0 (sv) Novel compounds and their use
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
HRPK20030233B3 (en) Process for the preparation of substituted phenylacetonitriles
DE60123034D1 (de) Herstellung von sekundären aminoisobutylalkoxysilanen
EA200100129A1 (ru) Способ получения гидроксиметилтиобутановой кислоты
TR200402547T4 (tr) Pantoprazol ve ara maddelerini hazırlamak için bir işlem.
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
ES2055503T3 (es) Diimida de silicio y procedimiento para su fabricacion, y para la fabricacion de nitruro de silicio generado a partir de la misma.
IT1320107B1 (it) Procedimento per la preparazione di derivati tassanici.
TR200400293T4 (tr) 9-dihidro-13-asetilbasatin III'e ait suda çözünebilir 9-dihidro-paklitaksel türevlerinin sentezi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties